Literature DB >> 5694600

Chloroquine seizures. Report of four cases.

E F Torrey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5694600     DOI: 10.1001/jama.204.10.867

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Seizure associated with chloroquine therapy in a patient with systemic lupus erythematosus.

Authors:  Antonio G Tristano; Luz Falcón; María Willson; Ivette Montes de Oca
Journal:  Rheumatol Int       Date:  2004-01-23       Impact factor: 2.631

Review 2.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1969-07       Impact factor: 2.401

3.  Convulsions associated with prophylactic antimalarial drugs: implications for people with epilepsy.

Authors:  D R Fish; M L Espir
Journal:  BMJ       Date:  1988 Aug 20-27

Review 4.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

Review 5.  The treatment of malaria.

Authors:  A P Hall
Journal:  Br Med J       Date:  1976-02-07

Review 6.  CNS adverse events associated with antimalarial agents. Fact or fiction?

Authors:  P A Phillips-Howard; F O ter Kuile
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

Review 7.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

8.  Seizures as a rare adverse effect of chloroquine therapy in systemic lupus erythematosus patients: a case report and literature survey.

Authors:  Piotr Krzeminski; Aleksandra Lesiak; Joanna Narbutt
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.